Structure-function analysis of Mullerian Inhibiting Substance (MIS)

苗勒管抑制物质(MIS)的结构-功能分析

基本信息

  • 批准号:
    10665653
  • 负责人:
  • 金额:
    $ 38.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-18 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary: Müllerian Inhibiting Substance (MIS) or Anti- Müllerian Hormone (AMH), originally identified for its role in male sex differentiation during development, has emerged as a significant molecule in female reproduction. For example, MIS plays an important role in regulating follicle development and serum levels and is now used as a measure of ovarian reserve. Mutations in MIS are associated with both male and female reproductive disorders, including Persistent Müllerian Duct Syndrome (PMDS) in males and Polycystic Ovary Syndrome (PCOS) in females. As a member of the TGFβ family, MIS signals through a type I and type II receptor. Uniquely, MIS signals through its own type II receptor MISRII and the type I receptor Alk2, which is utilized by multiple ligands. While previous studies have detailed TGFβ family ligand interactions, how MIS interacts, at the molecular level, with MISRII and Alk2 is unknown. The objective of this proposal is to understand how MIS interacts with its cognate receptors and how specific MIS signaling is generated through these receptors. Here, we will combine both structural and functional approaches, including X-ray crystallography, cell-based signaling assays, structure-based engineering, and biological models of fertility and ovarian protection. We will pursue the following three specific aims (1) determine the crystal structure of MIS with MISRII and Alk2, (2) characterize the MIS receptors and determine how the generate MIS-specific signaling, using both the extracellular and intercellular domains and (3) generate MIS analogs that will be tested in both in vitro binding and cell-based assays, along with in vivo assay including an AAV9 model of follicle suppression. Collectively, this proposal will uncover how MIS interacts with its receptors providing a platform for developing reagents that modify MIS activity with the potential for future application in reproductive therapies.

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structural Basis of Non-Latent Signaling by the Anti-Müllerian Hormone Procomplex.
抗苗勒管激素原复合物非潜在信号传导的结构基础。
  • DOI:
    10.1101/2024.04.01.587627
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Howard,JamesA;Hok,Lucija;Cate,RichardL;Sanford,NathanielJ;Hart,KaitlinN;Leach,EdmundAe;Bruening,AlenaS;Pépin,David;Donahoe,PatriciaK;Thompson,ThomasB
  • 通讯作者:
    Thompson,ThomasB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS B THOMPSON其他文献

THOMAS B THOMPSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS B THOMPSON', 18)}}的其他基金

Glacios 200 kV cryogenic transmission electron microscope (cryo-TEM)
Glacios 200 kV 低温透射电子显微镜 (cryo-TEM)
  • 批准号:
    10176876
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Structure-function analysis of Mullerian Inhibiting Substance (MIS)
苗勒管抑制物质(MIS)的结构-功能分析
  • 批准号:
    10471277
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Structure-function analysis of Mullerian Inhibiting Substance (MIS)
苗勒管抑制物质(MIS)的结构-功能分析
  • 批准号:
    10280107
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Structural/functional characterization of TGFβ superfamily signaling and regulation
TGFβ 超家族信号传导和调节的结构/功能表征
  • 批准号:
    10335177
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:
Regulation of GDF11 by extracellular mechanisms
细胞外机制对 GDF11 的调节
  • 批准号:
    10252072
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:
Regulation of GDF11 by extracellular mechanisms
细胞外机制对 GDF11 的调节
  • 批准号:
    10206827
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:
Regulation of GDF11 by extracellular mechanisms
细胞外机制对 GDF11 的调节
  • 批准号:
    10441552
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:
Structural/functional characterization of TGFβ superfamily signaling and regulation
TGFβ 超家族信号传导和调节的结构/功能表征
  • 批准号:
    10551878
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:
Regulation of GDF11 by extracellular mechanisms
细胞外机制对 GDF11 的调节
  • 批准号:
    10689719
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:
Structural/functional characterization of TGFβ superfamily signaling and regulation
TGFβ 超家族信号传导和调节的结构/功能表征
  • 批准号:
    10094061
  • 财政年份:
    2020
  • 资助金额:
    $ 38.94万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an anti-idiotype based vaccine for respiratory syncytial virus
呼吸道合胞病毒抗独特型疫苗的研制
  • 批准号:
    10414112
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion
利用遗传密码扩展开发针对尤文肉瘤的骨靶向抗体
  • 批准号:
    10600106
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion
利用遗传密码扩展开发针对尤文肉瘤的骨靶向抗体
  • 批准号:
    10383663
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Amyloid-inspired Vaccine Delivery for the Elderly
为老年人提供淀粉样蛋白疫苗
  • 批准号:
    10300848
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
Structure-function analysis of Mullerian Inhibiting Substance (MIS)
苗勒管抑制物质(MIS)的结构-功能分析
  • 批准号:
    10471277
  • 财政年份:
    2021
  • 资助金额:
    $ 38.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了